Robert F. Kennedy Jr.
Second MAHA Report Emphasizes Chronic Disease, Tilts at Vaccine Reform
MAHA Commission; chronic disease; vaccine reform; Robert F. Kennedy Jr.; childhood health; food policy; medication overuse; public health; federal directives; childhood vaccine schedule
Conflicts of Interest Among Federal Vaccine Advisors at Historic Lows Through 2024
conflicts of interest; vaccine advisory committees; ACIP; VRBPAC; CDC; FDA; transparency; Robert F. Kennedy Jr.; JAMA study
HHS Revives ’90s-Era Task Force to Improve Childhood Vaccine Safety
HHS; childhood vaccines; vaccine safety; task force; Robert F. Kennedy Jr.; Jay Bhattacharya; NIH; FDA; CDC; vaccine oversight; adverse reactions; childhood immunization schedule
HHS Cancels $500 Million in BARDA-Funded mRNA Vaccine Contracts Amid Strategic Shift
HHS; BARDA; mRNA vaccine; vaccine development; contract cancellation; Robert F. Kennedy Jr.; COVID-19; federal funding; Moderna; Pfizer; Seqirus
RFK Jr. Fires Top Deputies, Reshuffles Leadership at HHS
Robert F. Kennedy Jr.; Health and Human Services; leadership reshuffle; chief of staff; personnel changes; Matt Buckham; Trump loyalists; Heather Flick Melanson; Hannah Anderson
Trump’s CDC Nominee Susan Monarez Affirms Vaccine Safety and Access Commitment
Susan Monarez; CDC nominee; vaccines; Trump administration; vaccine safety; autism; Senate confirmation; Robert F. Kennedy Jr.; Gavi Vaccine Alliance
RFK Jr. Ousts All Members of CDC’s Vaccine Advisory Panel in ‘Clean Sweep’
RFK Jr.; CDC; vaccine advisory panel; Robert F. Kennedy Jr.; ACIP; clean sweep; public trust; HHS
Trump Establishes Make America Healthy Again Commission to Combat Childhood Chronic Diseases
MAHA Commission, Robert F. Kennedy Jr., childhood chronic diseases, HHS Secretary, Executive Order, public health, chronic illness, disease prevention
Trump’s Return to the White House: Potential Implications for FDA and Biopharma M&A
Trump, FDA, Biopharma, M&A, Healthcare Policy, Robert F. Kennedy Jr.